Physical Activity, Depression and Quality of Life in COPD - Results from the CLARA II Study.

"Disclosure Dr Horst Olschewski reports personal fees and/or non-financial support from Astra Zeneca, Boehringer, Menarini; personal fees from Chiesi, GSK and Novartis, outside the submitted work. Dr Sylvia Hartl reports grants and/or personal fees from GSK, Astra Zeneca, Menarini Pharma, Chiesi Farma, Roche Pharma, and MSD, outside the submitted work. Professor Arschang Valipour reports personal fees from Astra Zeneca, Boehringer Ingelheim, Chiesi, GSK, and Menarini, during the conduct of the study. Dr Georg-Christian Funk reports honorary for advisory board from Menarini Pharma. Dr Monika Merkle reports personal fees from Astra Zeneca, Boehringer Ingelheim, Chiesi, Menarini, Sanofi, and Novartis, outside the submitted work. Mrs Eva Wallner and Dr Stephan Brecht are employees of A. Menarini Pharma GmbH. The authors report no other conflicts of interest in this work."

"Funding of this study was provided by A. Menarini Pharma GmbH. The funding source had no role in data analysis, interpretation of the data, or decision to submit results."